Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › CA › Milpitas › NPI 1396837605
Lab

Igenex INC

Igenex INC was paid $2.04M by Medicaid between May 2020 and Jul 2024, across 4 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 86% of everything it billed.

33Billing provider infoIGENEX INC
MILPITAS, CA 95035
33aNPI1396837605assigned 09/28/2006
28Total paid$2.04M
24GClaims49,139
24DCodes billed4
24AFirst – last monthMay 2020 – Jul 2024
Compared with peers

Next to other Clinical Medical Laboratory providers in California

Rank by total paid#149 of 561
Median peer was paid$222K
This provider vs. median9.2×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$100K$200K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20202,671$96K
202113,023$427K
202228,909$1.21M
20234,189$282K
2024incomplete347$28K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 86% 35,813 15,391 $1.77M
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 5.6% 11,314 4,965 $115K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 4.0% 1,077 694 $82K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV 3.9% 935 505 $80K

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialSHAH, JYOTSNA (CEO/ LAB DIRECTOR)